Glen Eagle Advisors, LLC Edwards Lifesciences Corp Transaction History

Glen Eagle Advisors, LLC

  • $593 Billion
  • Q3 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 13,369 shares of EW stock, worth $1 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
13,369
Previous 14,425 7.32%
Holding current value
$1 Million
Previous $1.33 Billion 33.79%
% of portfolio
0.15%
Previous 0.24%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$59.7 - $93.78 $63,043 - $99,031
-1,056 Reduced 7.32%
13,369 $882 Million
Q2 2024

Aug 14, 2024
BUY
$84.3 - $94.31 $1.19 Million - $1.34 Million
14,165 Added 5448.08%
14,425 $1.33 Billion
Q1 2024

Jul 03, 2024
BUY
$72.54 - $95.56 $686,228 - $903,997
9,460 New
9,460 $904 Million
Q4 2023

Aug 13, 2024
BUY
$61.71 - $77.76 $86,270 - $108,708
1,398 Added 209.6%
2,065 $157 Million
Q3 2021

Aug 13, 2024
SELL
$102.91 - $122.75 $2,366 - $2,823
-23 Reduced 3.33%
667 $75.5 Million
Q4 2020

Aug 13, 2024
SELL
$71.69 - $91.23 $628,721 - $800,087
-8,770 Reduced 92.71%
690 $62.9 Million
Q3 2020

Aug 13, 2024
SELL
$67.19 - $87.44 $201 - $262
-3 Reduced 0.39%
765 $61.1 Million
Q2 2020

Aug 13, 2024
BUY
$57.54 - $76.95 $30,956 - $41,399
538 Added 233.91%
768 $53.1 Million
Q1 2020

Aug 13, 2024
SELL
$52.41 - $81.0 $1,729 - $2,673
-33 Reduced 12.55%
230 $43.4 Million
Q4 2019

Aug 13, 2024
BUY
$71.7 - $82.09 $71 - $82
1 Added 0.38%
263 $61.4 Million
Q3 2019

Aug 13, 2024
BUY
$61.55 - $75.43 $1,969 - $2,413
32 Added 13.91%
262 $57.6 Million
Q1 2019

Aug 13, 2024
SELL
$47.89 - $64.05 $442,024 - $591,181
-9,230 Reduced 97.57%
230 $44 Million
Q4 2018

Aug 13, 2024
SELL
$46.41 - $56.94 $1,160 - $1,423
-25 Reduced 9.8%
230 $35.2 Million
Q3 2018

Aug 13, 2024
SELL
$45.7 - $58.03 $182 - $232
-4 Reduced 1.54%
255 $44.4 Million
Q2 2018

Aug 13, 2024
SELL
$42.45 - $51.3 $1.35 Million - $1.63 Million
-31,861 Reduced 99.19%
259 $37.7 Million
Q1 2018

Aug 14, 2024
SELL
$37.19 - $47.45 $342,148 - $436,540
-9,200 Reduced 97.25%
260 $36.3 Million
Q1 2018

Aug 13, 2024
BUY
$37.19 - $47.45 $1.19 Million - $1.52 Million
32,101 Added 168952.62%
32,120 $36.3 Million
Q4 2017

Aug 13, 2024
SELL
$33.79 - $39.39 $14,800 - $17,252
-438 Reduced 95.84%
19 $2.14 Million
Q3 2017

Aug 13, 2024
SELL
$36.29 - $38.83 $326,718 - $349,586
-9,003 Reduced 95.17%
457 $50 Million
Q2 2017

Aug 12, 2024
BUY
N/A
25 Added 14.29%
200 $23.6 Million
Q1 2017

Aug 12, 2024
BUY
N/A
50 Added 40.0%
175 $16.5 Million
Q4 2016

Aug 12, 2024
SELL
N/A
-9,335
125 $11.7 Million

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
457M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email